Among these candidate targets, TAZ was predicted as a novel target of miR-141 and was selected as our target gene in GC for further study, as it seemed more germane to present study and has been shown to associate with prognosis and metastasis in patients with breast cancers. This evidence concerns the gene WWTR1 and breast carcinoma.